Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) (NCT07101094)

🧪 Interventions in This Study

• xanomeline and trospium chloride (X/T) therapy (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (20 Sites)

• ATP Clinical Research — Costa Mesa, California
• Lumos Clinical Research Center — San Jose, California
• Local Institution - 0019 — Miami, Florida
• Evanston Hospital — Evanston, Illinois
• The Johns Hopkins Hospital — Baltimore, Maryland
• Local Institution - 0017 — Bel Air, Maryland
• Local Institution - 0004 — Catonsville, Maryland
• Local Institution - 0008 — Belmont, Massachusetts
• Boston Medical Center — Boston, Massachusetts
• Mayflower Clinical — South Dartmouth, Massachusetts
• Local Institution - 0020 — Grand Island, Nebraska
• Omaha Insomnia and Psychiatric Services — Omaha, Nebraska
• Hackensack Meridian Health - Carrier Clinic — Belle Mead, New Jersey
• Radial - Manhattan — New York, New York
• New Dawn Psychiatric Services, PLLC — Kinston, North Carolina
• New Dimension Group — Rose Hill, North Carolina
• Westlake Brain Health — Westlake, Ohio
• Continuum Health Providers — Fort Mill, South Carolina
• Haracec Clinical Research — El Paso, Texas
• C-Trilogy Outreach — Longview, Texas

📞 Contact the Study Coordinator

Phone: (855) 907-3286

Email: Clinical.Trials@bms.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Schizophrenia

• Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
• Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
• Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
• Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
• Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
• Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia

Explore by condition: All Schizophrenia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.